Predictive Oncology Develops 3D Liver Toxicity Models for Labcorp

MT Newswires Live
06/12

Predictive Oncology (POAI) said Thursday that it has developed two 3D liver toxicity models exclusively for Labcorp (LH).

The models simulate human and rat liver environments and can be used to evaluate and predict drug clearance, drug transport, and liver toxicity related to drugs, as well as provide insights into how cancer treatments might work in patients, according to the company.

Tests showed that the models were functional for up to 14 days, the company said.

Shares of Predictive Oncology were up 1.7%, while Labcorp was down 0.1% in recent trading.

Price: 1.00, Change: +0.02, Percent Change: +1.73

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10